Follow
Enda Cindylosa Sitepu, MD
Enda Cindylosa Sitepu, MD
Medical Doctor, Cellcure Center, Gatot Soebroto Army Central Hospital
Verified email at mail.ugm.ac.id
Title
Cited by
Cited by
Year
Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?
J Jonny, TA Putranto, EC Sitepu, R Irfon
Expert Review of Vaccines 21 (8), 1111-1120, 2022
112022
Necrosis factor-α (TNF-α) and the presence of macrophage M2 and T regulatory cells in nasopharyngeal carcinoma
I Mardhiyah, YN Ardiyan, SH Aliyah, EC Sitepu, C Herdini, ...
Asian Pacific Journal of Cancer Prevention: APJCP 22 (8), 2363, 2021
52021
Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
J Jonny, TA Putranto, R Irfon, EC Sitepu
Frontiers in immunology 13, 989685, 2022
42022
Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result
J Jonny, TA Putranto, ML Yana, EC Sitepu, R Irfon, BP Ramadhani, ...
Frontiers in Immunology 14, 1122389, 2023
12023
Neuroprotective effect of ethanolic extract of Pandanus Odoratissimus Ln. in Paraquat mice model of Parkinson's disease
EC Sitepu, R Adji, AK Tedja, S Simanjaya
Parkinsonism & Related Disorders 22, e187, 2016
12016
Ex Vivo-Generated Tolerogenic Dendritic Cells: Hope for a Definitive Therapy of Autoimmune Diseases
Jonny, EC Sitepu, CA Nidom, S Wirjopranoto, IK Sudiana, ANM Ansori, ...
Current Issues in Molecular Biology 46 (5), 4035-4048, 2024
2024
Significant improvement of systemic lupus erythematosus manifestation in children after autologous dendritic cell transfer: a case report and review of literature
RI Jonny, Terawan Agus Putranto, Yenny Purnama, Roedi Djatmiko, Martina Lily ...
Therapeutic Advances in Vaccines and Immunotherapy 11, 2023
2023
Hepcidin in Hemodialysis Patients: An Update Review
J Jonny, EC Sitepu, KA Azzalyka, TF Pasiak
The system can't perform the operation now. Try again later.
Articles 1–8